Cargando…

Safeguarding against use of contaminated COVID-19 Vaccine Janssen

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211950/
http://dx.doi.org/10.1007/s40278-021-97464-3
_version_ 1783709577520349184
collection PubMed
description
format Online
Article
Text
id pubmed-8211950
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82119502021-06-21 Safeguarding against use of contaminated COVID-19 Vaccine Janssen Reactions Weekly News Item Springer International Publishing 2021-06-19 2021 /pmc/articles/PMC8211950/ http://dx.doi.org/10.1007/s40278-021-97464-3 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
Safeguarding against use of contaminated COVID-19 Vaccine Janssen
title Safeguarding against use of contaminated COVID-19 Vaccine Janssen
title_full Safeguarding against use of contaminated COVID-19 Vaccine Janssen
title_fullStr Safeguarding against use of contaminated COVID-19 Vaccine Janssen
title_full_unstemmed Safeguarding against use of contaminated COVID-19 Vaccine Janssen
title_short Safeguarding against use of contaminated COVID-19 Vaccine Janssen
title_sort safeguarding against use of contaminated covid-19 vaccine janssen
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211950/
http://dx.doi.org/10.1007/s40278-021-97464-3